TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues

Autor: Krajewska M, Krajewski S, Jm, Zapata, Van Arsdale T, Rd, Gascoyne, Berern K, McFadden D, Ahmed Shabaik, Hugh J, Reynolds A, Cv, Clevenger, Jc, Reed

Publikováno v: ResearcherID
American Journal Of Pathology, vol 152, iss 6
Scopus-Elsevier
Europe PubMed Central

TRAF-4 was discovered because of its expression in breast cancers and is a member of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) family of putative signal-transducing proteins. In vitro binding assays demonstrated that TRAF-4 in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5a6d19fdb4fb918c82b1fe492cd5fcb7
https://pubmed.ncbi.nlm.nih.gov/9846990

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma

Autor: Ah, Banham, Jm, Connors, Pj, Brown, Jl, Cordell, Ott G, Sreenivasan G, Pedro Farinha, Horsman DE, Rd, Gascoyne

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6d9462e2d3e4b19fee7fce8677875326
http://europepmc.org/abstract/med/15709173

Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family

Autor: Krajewski S, Jm, Zapata, Krajewska M, VanArsdale T, Ahmed Shabaik, Rd, Gascoyne, Jc, Reed

Publikováno v: Europe PubMed Central

An immunohistochemical approach was used to explore the in vivo expression of TNF receptor-associated factor 3 (TRAF-3), a putative signaling protein that binds to the cytosolic domains of CD30, CD40, and lymphotoxin-beta receptors. TRAF-3 immunostai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d7684a06510a1219741f880a247d61e6
http://europepmc.org/abstract/med/9550380

A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency.

Autor: KM Ramadan¹, T Shenkier², LH Sehn², RD Gascoyne³, JM Connors²

Publikováno v: Annals of Oncology. Jan2007, Vol. 18 Issue 1, p129-135. 7p.

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.

Autor: Alduaij W; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; UBC Clinician Investigator Program, The University of British Columbia, Vancouver, BC, Canada., Collinge B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Jiang A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Hilton LK; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Boyle M; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Meissner B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Chong L; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Miyata-Takata T; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Slack GW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Farinha P; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Craig JW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Lytle A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Savage KJ; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Villa D; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Freeman CL; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Gascoyne RD; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Connors JM; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Morin RD; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Steidl C; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.

Publikováno v: Blood [Blood] 2023 May 18; Vol. 141 (20), pp. 2493-2507.